Published in Proteomics Weekly, August 21st, 2006
Study 1: Topical application of an Escherichia coli-vectored vaccine is a simple method for eliciting protective immunity.
According to a study from the United States, "We report that animals can be protected against lethal infection by Clostridium tetani cells and Bacillus anthracis spores following topical application of intact particles of live or gamma-irradiated Escherichia coli vectors overproducing tetanus and anthrax antigens, respectively."
"Cutaneous gamma delta T cells were rapidly recruited to the administration site,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
Source: Proteomics Weekly (2006-08-21)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.